 Connection
David Magid to Ticlopidine
This is a "connection" page, showing publications David Magid has written about Ticlopidine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.021 |
|
|
|
-
Xu S, Shetterly S, Raebel MA, Ho PM, Tsai TT, Magid D. Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment. Pharmacoepidemiol Drug Saf. 2014 Aug; 23(8):812-8.
Score: 0.447
-
Xu S, Shetterly S, Powers D, Raebel MA, Tsai TT, Ho PM, Magid D. Extension of Kaplan-Meier methods in observational studies with time-varying treatment. Value Health. 2012 Jan; 15(1):167-74.
Score: 0.378
-
Tsai TT, Ho PM, Xu S, Powers JD, Carroll NM, Shetterly SM, Maddox TM, Rumsfeld JS, Margolis K, Go AS, Magid DJ. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Circ Cardiovasc Interv. 2010 Jun 01; 3(3):230-5.
Score: 0.342
-
Ho PM, Tsai TT, Maddox TM, Powers JD, Carroll NM, Jackevicius C, Go AS, Margolis KL, DeFor TA, Rumsfeld JS, Magid DJ. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):261-6.
Score: 0.341
-
Ho PM, Tsai TT, Wang TY, Shetterly SM, Clarke CL, Go AS, Sedrakyan A, Rumsfeld JS, Peterson ED, Magid DJ. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):303-8.
Score: 0.340
-
Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008 Feb 06; 299(5):532-9.
Score: 0.073
-
Ho PM, Fihn SD, Wang L, Bryson CL, Lowy E, Maynard C, Magid DJ, Peterson ED, Jesse RL, Rumsfeld JS. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J. 2007 Nov; 154(5):846-51.
Score: 0.072
-
Wang TY, Magid DJ, Ting HH, Li S, Alexander KP, Roe MT, Peterson ED. The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention. Am Heart J. 2014 Jun; 167(6):833-9.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|